Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 123385
Published online Nov 15, 2026. doi: 10.4251/wjgo.123385
Published online Nov 15, 2026. doi: 10.4251/wjgo.123385
Table 2 Best tumor responses as per Response Evaluation Criteria in Solid Tumors version 1.1 between the regorafenib combined with programmed cell death-1 inhibitor and regorafenib monotherapy groups, n (%)
| Best Response | Overall response | Intrahepatic response | Extrahepatic response | ||||||
| RP group | R group | P value | RP group | R group | P value | RP group | R group | P value | |
| CR | 0 (0.00) | 0 (0.00) | 1.000 | 0 (0.00) | 0 (0.00) | 1.000 | 0 (0.00) | 0 (0.00) | 1.000 |
| PR | 4 (3.96) | 0 (0.00) | 0.576 | 4 (3.96) | 0 (0.00) | 0.575 | 3 (5.77) | 0 (0.00) | 0.550 |
| SD | 66 (65.35) | 15 (38.46) | 0.005 | 80 (79.21) | 23 (58.97) | 0.031 | 28 (53.85) | 7 (31.82) | 0.126 |
| PD | 31 (30.69) | 24 (61.54) | 0.001 | 17 (16.83) | 15 (38.46) | 0.007 | 21 (40.38) | 15 (68.18) | 0.042 |
| ORR | 4 (3.96) | 0 (0.00) | 0.576 | 4 (3.96) | 0 (0.00) | 0.575 | 3 (5.77) | 0 (0.00) | 0.550 |
| DCR | 70 (69.31) | 15 (38.46) | 0.001 | 84 (83.17) | 23 (58.97) | 0.007 | 31 (59.62) | 7 (31.82) | 0.0042 |
- Citation: Ma F, Zheng LY, Song DJ, Zhao ZW, Cao F, Hao WY, Qiu JQ, Lu D, Zheng JP. Regorafenib combined with programmed death inhibitor after initial treatment failure in unresectable hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(11): 123385
- URL: https://www.wjgnet.com/1948-5204/full/v18/i11/123385.htm
- DOI: https://dx.doi.org/10.4251/wjgo.123385